We have an increasing palette of therapies that can lower low-density lipoprotein (LDL) cholesterol, a causal risk factor for atherosclerotic cardiovascular disease (ASCVD). These include nonstatin alternatives that have proven efficacy in event reduction. Yet, we have not extinguished lipid risk for ASCVD. Fortunately, we have new approaches for addressing lipid risk factors, including LDL and beyond. This session offers updated knowledge on lipid risk and new tools for lipid management available today, as well as those in development, to lower ASCVD risk.
- Provider:Pri-Med Institute
- Activity Link: https://www.pri-med.com/online-cme-ce/virtual-cme-program/cardiologynow-november-12-cme1-cardiology
- Start Date: 2024-11-12 06:00:00
- End Date: 2024-11-12 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Endocrinology, Diabetes, and Metabolism, Internal Medicine
Subscribe
Login
0 Comments
Oldest